Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 203

1.

Randomized placebo-controlled adjunctive study of an extract of withania somnifera for cognitive dysfunction in bipolar disorder.

Chengappa KN, Bowie CR, Schlicht PJ, Fleet D, Brar JS, Jindal R.

J Clin Psychiatry. 2013 Nov;74(11):1076-83. doi: 10.4088/JCP.13m08413.

2.

Placebo-controlled adjunctive trial of pramipexole in patients with bipolar disorder: targeting cognitive dysfunction.

Burdick KE, Braga RJ, Nnadi CU, Shaya Y, Stearns WH, Malhotra AK.

J Clin Psychiatry. 2012 Jan;73(1):103-12. doi: 10.4088/JCP.11m07299. Epub 2011 Nov 29.

3.

Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: a double-blind, randomized, placebo-controlled phase 2 trial.

Miskowiak KW, Ehrenreich H, Christensen EM, Kessing LV, Vinberg M.

J Clin Psychiatry. 2014 Dec;75(12):1347-55. doi: 10.4088/JCP.13m08839.

PMID:
25099079
4.

Cognitive functioning and acute sedative effects of risperidone and quetiapine in patients with stable bipolar I disorder: a randomized, double-blind, crossover study.

Harvey PD, Hassman H, Mao L, Gharabawi GM, Mahmoud RA, Engelhart LM.

J Clin Psychiatry. 2007 Aug;68(8):1186-94.

PMID:
17854242
5.

Neurocognitive functioning in patients with bipolar I disorder recently recovered from a first manic episode.

Torres IJ, DeFreitas VG, DeFreitas CM, Kauer-Sant'Anna M, Bond DJ, Honer WG, Lam RW, Yatham LN.

J Clin Psychiatry. 2010 Sep;71(9):1234-42. doi: 10.4088/JCP.08m04997yel. Epub 2010 Mar 23.

PMID:
20361907
6.

Neuropsychological profile in bipolar disorder: a preliminary study of monotherapy lithium-treated euthymic bipolar patients evaluated at a 2-year interval.

Mur M, Portella MJ, Martínez-Arán A, Pifarré J, Vieta E.

Acta Psychiatr Scand. 2008 Nov;118(5):373-81. doi: 10.1111/j.1600-0447.2008.01245.x. Epub 2008 Aug 27.

PMID:
18759809
7.

A randomized, double-blind, controlled trial evaluating the effect of intranasal insulin on neurocognitive function in euthymic patients with bipolar disorder.

McIntyre RS, Soczynska JK, Woldeyohannes HO, Miranda A, Vaccarino A, Macqueen G, Lewis GF, Kennedy SH.

Bipolar Disord. 2012 Nov;14(7):697-706. doi: 10.1111/bdi.12006.

PMID:
23107220
8.

The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) for mood disorders: double-blind, placebo-controlled studies.

Zhang ZJ, Kang WH, Li Q, Tan QR.

J Psychiatr Res. 2007 Nov;41(10):828-36. Epub 2006 Sep 29.

PMID:
17010995
9.

Long-term stability of cognitive impairment in bipolar disorder: a 2-year follow-up study of lithium-treated euthymic bipolar patients.

Mur M, Portella MJ, Martínez-Arán A, Pifarré J, Vieta E.

J Clin Psychiatry. 2008 May;69(5):712-9.

PMID:
18435565
10.

Supraphysiologic doses of levothyroxine as adjunctive therapy in bipolar depression: a randomized, double-blind, placebo-controlled study.

Stamm TJ, Lewitzka U, Sauer C, Pilhatsch M, Smolka MN, Koeberle U, Adli M, Ricken R, Scherk H, Frye MA, Juckel G, Assion HJ, Gitlin M, Whybrow PC, Bauer M.

J Clin Psychiatry. 2014 Feb;75(2):162-8. doi: 10.4088/JCP.12m08305.

PMID:
24345793
11.

Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial.

Bowden CL, Vieta E, Ice KS, Schwartz JH, Wang PP, Versavel M.

J Clin Psychiatry. 2010 Feb;71(2):130-7. doi: 10.4088/JCP.09m05482yel. Epub 2010 Jan 26.

PMID:
20122373
12.

Executive function and attention span in euthymic patients with bipolar 1 disorder.

Normala I, Abdul HA, Azlin B, Nik Ruzyanei NJ, Hazli Z, Shah SA.

Med J Malaysia. 2010 Sep;65(3):199-203.

13.

A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently.

Macfadden W, Alphs L, Haskins JT, Turner N, Turkoz I, Bossie C, Kujawa M, Mahmoud R.

Bipolar Disord. 2009 Dec;11(8):827-39. doi: 10.1111/j.1399-5618.2009.00761.x.

PMID:
19922552
14.

Acute efficacy of divalproex sodium versus placebo in mood stabilizer-naive bipolar I or II depression: a double-blind, randomized, placebo-controlled trial.

Muzina DJ, Gao K, Kemp DE, Khalife S, Ganocy SJ, Chan PK, Serrano MB, Conroy CM, Calabrese JR.

J Clin Psychiatry. 2011 Jun;72(6):813-9. doi: 10.4088/JCP.09m05570gre. Epub 2010 Aug 24.

PMID:
20816041
15.

Cognitive functioning in euthymic bipolar I and bipolar II patients.

Dittmann S, Hennig-Fast K, Gerber S, Seemüller F, Riedel M, Emanuel Severus W, Langosch J, Engel RR, Möller HJ, Grunze HC.

Bipolar Disord. 2008 Dec;10(8):877-87. doi: 10.1111/j.1399-5618.2008.00640.x.

PMID:
19594503
16.

Long-term outcome of cognitive impairment in bipolar disorder.

Torrent C, Martinez-Arán A, del Mar Bonnin C, Reinares M, Daban C, Solé B, Rosa AR, Tabarés-Seisdedos R, Popovic D, Salamero M, Vieta E.

J Clin Psychiatry. 2012 Jul;73(7):e899-905. doi: 10.4088/JCP.11m07471.

PMID:
22901360
17.

Comparison of neuropsychological effects of adjunctive risperidone or quetiapine in euthymic patients with bipolar I disorder.

Kozicky JM, Torres IJ, Bond DJ, Lam RW, Yatham LN.

Int Clin Psychopharmacol. 2012 Mar;27(2):91-9. doi: 10.1097/YIC.0b013e32834e3bea.

PMID:
22124206
18.

The effect of duloxetine treatment on cognition in patients with fibromyalgia.

Mohs R, Mease P, Arnold LM, Wang F, Ahl J, Gaynor PJ, Wohlreich MM.

Psychosom Med. 2012 Jul-Aug;74(6):628-34. doi: 10.1097/PSY.0b013e31825b9855. Epub 2012 Jun 28.

PMID:
22753629
19.
20.

Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial.

Sachs GS, Ice KS, Chappell PB, Schwartz JH, Gurtovaya O, Vanderburg DG, Kasuba B.

J Clin Psychiatry. 2011 Oct;72(10):1413-22. doi: 10.4088/JCP.09m05934.

PMID:
21672493

Supplemental Content

Support Center